{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T00:15:55Z","timestamp":1794528955790,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malawi adopted the 2012 updated Word Health Organization (WHO) Intermittent preventive treatment of malaria during pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) policy in 2013. This study aimed to estimate the proportion of and identify factors associated with the uptake of at least three doses of IPTp with SP among pregnant women in Malawi after the adoption and operationalisation of updated WHO IPTp-SP policy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The 2015\u201316 Malawi Demographic and Health Survey dataset was analysed. Of 1219 women aged 15\u201349\u2009years who had live births and the children were born after the date of July 2015, 1069 women were included in the analysis. Bivariate and multiple logistic regression were used in data analysis. The statistical analysis took into account a complex survey sample design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 1069 women, 447 (42, 95% CI: 38.1\u201345.6) received three (optimal) or more doses of IPTp-SP. Less than half (47%) managed to attend at least four antenatal care (ANC) clinics. Only 52% received optimal SP doses among those who made at least four ANC visits. Only the number of ANC visits was associated with the optimal uptake of SP. Women who attended ANC three times only and those who visited ANC once or twice only were less likely to receive at least three doses of SP than those who managed to attend ANC at least four times during pregnancy (AOR\u2009=\u20090.71, 95% CI 0.49\u20131.02) and (AOR\u2009=\u20090.12, 95% CI 0.06\u20130.21) respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>To achieve effective malaria prevention in pregnancy, IPTP-SP is used alongside other interventions. However, there is low uptake of optimal SP doses in Malawi, and this seems to be associated with the number of ANC visits. Moreover, there is limited effectiveness of an increased number of ANC visits on the uptake of optimal SP doses. Further research should be done to explore health systems factors affecting uptake of optimal IPTp with SP doses during pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-020-08471-5","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T10:07:01Z","timestamp":1584353221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015\u20132016"],"prefix":"10.1186","volume":"20","author":[{"given":"Steven Chifundo","family":"Azizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,16]]},"reference":[{"key":"8471_CR1","doi-asserted-by":"publisher","first-page":"e1000221","DOI":"10.1371\/journal.pmed.1000221","volume":"7","author":"S Dellicour","year":"2010","unstructured":"Dellicour S, Tatem A, Guerra C, Snow R, ter Kuile F. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 2010;7:e1000221.","journal-title":"PLoS Med"},{"key":"8471_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4269\/ajtmh.2001.64.36","volume":"64","author":"H Guyatt","year":"2001","unstructured":"Guyatt H, Snow R. The epidemiology and burden of plasmodium falciparum -related anemia among pregnant women in sub-Saharan Africa. Am J Trop Med Hyg. 2001;64:36\u201344.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"8471_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S1473-3099(07)70024-5","volume":"7","author":"C Men\u00e9ndez","year":"2007","unstructured":"Men\u00e9ndez C, D'Alessandro U, ter Kuile FO. Reducing the burden of malaria in pregnancy by preventive strategies. Lancet Infect Dis. 2007;7(2):126\u201335.","journal-title":"Lancet Infect Dis"},{"key":"8471_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1473-3099(07)70021-X","volume":"7","author":"M Desai","year":"2007","unstructured":"Desai M, ter Kuile F, Nosten F, McGready R, Asamoa K, Brabin B, Newman R. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007;7:93\u2013104.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"8471_CR5","doi-asserted-by":"publisher","first-page":"e1001488","DOI":"10.1371\/journal.pmed.1001488","volume":"10","author":"J Hill","year":"2013","unstructured":"Hill J, Hoyt J, van Eijk AM, D'Mello-Guyett L, Ter Kuile FO, Steketee R, Smith H, Webster J. Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med. 2013;10(7):e1001488.","journal-title":"PLoS Med"},{"key":"8471_CR6","unstructured":"Partnership RBM. The contribution of malaria control to maternal and newborn health. In: Progress & impact Geneva: World Health Organization; 2014. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/126340\/9789241507219_eng.pdf."},{"key":"8471_CR7","first-page":"932895","volume":"2011","author":"CO Agomo","year":"2011","unstructured":"Agomo CO, Oyibo WA, Odukoya-Maije F. Parasitologic assessment of two-dose and monthly intermittent preventive treatment of malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTP-SP) in Lagos. Nigeria Malar Res Treat. 2011;2011:932895.","journal-title":"Nigeria Malar Res Treat"},{"key":"8471_CR8","unstructured":"Malaria and Pregnancy [http:\/\/www.malariasite.com\/pregnancy\/]."},{"issue":"1","key":"8471_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-016-0759-3","volume":"15","author":"KG Dimasuay","year":"2017","unstructured":"Dimasuay KG, Aitken EH, Rosario F, Njie M, Glazier J, Rogerson SJ, Fowkes FJ, Beeson JG, Powell T, Jansson T. Inhibition of placental mTOR signaling provides a link between placental malaria and reduced birthweight. BMC Med. 2017;15(1):1.","journal-title":"BMC Med"},{"issue":"6 Suppl","key":"8471_CR10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4269\/ajtmh.77.6.suppl.14","volume":"77","author":"SJ Rogerson","year":"2007","unstructured":"Rogerson SJ, Mwapasa V, Meshnick SR. Malaria in pregnancy: linking immunity and pathogenesis to prevention. Am J Trop Med Hyg. 2007;77(6 Suppl):14\u201322.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"8471_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4269\/ajtmh.2001.64.28","volume":"64","author":"R Steketee","year":"2001","unstructured":"Steketee R, Nahlen B, Parise M, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med hyg. 2001;64(1):28\u201335.","journal-title":"Am J Trop Med hyg"},{"issue":"3","key":"8471_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jmwh.2008.02.012","volume":"53","author":"RE Lagerberg","year":"2008","unstructured":"Lagerberg RE. Malaria in pregnancy: a literature review. J Midwifery Womens Health. 2008;53(3):209\u201315.","journal-title":"J Midwifery Womens Health"},{"issue":"6","key":"8471_CR13","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jama.2012.216231","volume":"309","author":"K Kayentao","year":"2013","unstructured":"Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, MacArthur JR, Luntamo M, Ashorn P, Doumbo OK, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. Jama. 2013;309(6):594\u2013604.","journal-title":"Jama"},{"issue":"12","key":"8471_CR14","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1473-3099(12)70222-0","volume":"12","author":"TP Eisele","year":"2012","unstructured":"Eisele TP, Larsen DA, Anglewicz PA, Keating J, Yukich J, Bennett A, Hutchinson P, Steketee RW. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infect Dis. 2012;12(12):942\u20139.","journal-title":"Lancet Infect Dis"},{"key":"8471_CR15","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1128\/CMR.17.4.760-769.2004","volume":"17","author":"H Guyatt","year":"2004","unstructured":"Guyatt H, Snow R. Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev. 2004;17:760\u20139.","journal-title":"Clin Microbiol Rev"},{"key":"8471_CR16","volume-title":"Malawi Strategic Plan 2011\u20132015: Towards Universal Acess","author":"National Malaria Control Programme (NMCP) [Malawi]","year":"2010","unstructured":"National Malaria Control Programme (NMCP) [Malawi]. Malawi Strategic Plan 2011\u20132015: Towards Universal Acess. Lilongwe: NMCP; 2010."},{"issue":"8","key":"8471_CR17","doi-asserted-by":"publisher","first-page":"e12012","DOI":"10.1371\/journal.pone.0012012","volume":"5","author":"G Feng","year":"2010","unstructured":"Feng G, Simpson JA, Chaluluka E, Molyneux ME, Rogerson SJ. Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets. PLoS One. 2010;5(8):e12012.","journal-title":"PLoS One"},{"key":"8471_CR18","unstructured":"WHO. A Strategic Framework for Malaria Prevention and Control During Pregnancy in the African Region. In:., vol. (AFR\/MAL\/04\/01). Brazzaville, Congo: World Health Organization Regional Office for Africa;2004. http:\/\/whqlibdoc.who.int\/afro\/2004\/AFR_MAL_04.01.pdf."},{"key":"8471_CR19","unstructured":"WHO. Malaria in Pregnancy Guidelines for Measuring Key Monitoring and Evaluation Indictors. 2007. http:\/\/whqlibdoc.who.int\/publications\/2007\/9789241595636_eng.pdf. Accessed 24 Nov 2015."},{"key":"8471_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-015-1033-4","volume":"14","author":"KG Andrews","year":"2015","unstructured":"Andrews KG, Lynch M, Eckert E, Gutman J. Missed opportunities to deliver intermittent preventive treatment for malaria to pregnant women 2003-2013: a systematic analysis of 58 household surveys in sub-Saharan Africa. Malar J. 2015;14:1\u201310.","journal-title":"Malar J"},{"key":"8471_CR21","volume-title":"Updated WHO policy recommendation: intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP)","author":"WHO","year":"2012","unstructured":"WHO. Updated WHO policy recommendation: intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). Geneva: World Health Organization; 2012. [Accessed on Nov 20, 2015]. Available from http:\/\/www.who.int\/malaria\/publications\/atoz\/who_iptp_sp_policy_recommendation\/en\/. In.: Geneva: World Health Organization."},{"issue":"1","key":"8471_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/1475-2875-13-455","volume":"13","author":"FJ Mpogoro","year":"2014","unstructured":"Mpogoro FJ, Matovelo D, Dosani A, Ngallaba S, Mugono M, Mazigo HD. Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania. Malar J. 2014;13(1):455.","journal-title":"Malar J"},{"issue":"23","key":"8471_CR23","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1001\/jama.297.23.2603","volume":"297","author":"FO ter Kuile","year":"2007","unstructured":"ter Kuile FO, van Eijk AM, Filler SJ. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. Jama. 2007;297(23):2603\u201316.","journal-title":"Jama"},{"issue":"11","key":"8471_CR24","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1086\/522233","volume":"196","author":"FO ter Kuile","year":"2007","unstructured":"ter Kuile FO, Steketee RW. Intermittent preventive therapy with sulfadoxine-pyrimethamine during pregnancy: seeking information on optimal dosing frequency. J Infect Dis. 2007;196(11):1574\u20136.","journal-title":"J Infect Dis"},{"key":"8471_CR25","volume-title":"Evidence review group: Intermittent preventive treatment of malaria in pregnancy (IPTp) with sulfadoxine\u2013pyrimethamine (SP)","author":"WHO","year":"2012","unstructured":"WHO. Evidence review group: Intermittent preventive treatment of malaria in pregnancy (IPTp) with sulfadoxine\u2013pyrimethamine (SP). Geneva: World Health Organization; 2012. Available from http:\/\/www.who.int\/malaria\/mpac\/sep2012\/iptp_sp_erg_meeting_report_july2012.pdf."},{"key":"8471_CR26","doi-asserted-by":"crossref","unstructured":"Desai M, Hill J, Fernandes S, Walker P, Pell C, Gutman J, Kayentao K, Gonzalez R, Webster J, Greenwood B. Prevention of malaria in pregnancy. Lancet Infect Dis. 2018;18(4):e119\u201332.","DOI":"10.1016\/S1473-3099(18)30064-1"},{"issue":"1","key":"8471_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12936-017-1736-9","volume":"16","author":"CA Mwendera","year":"2017","unstructured":"Mwendera CA, Jager C, Longwe H, Phiri K, Hongoro C, Mutero CM. Changing the policy for intermittent preventive treatment with sulfadoxine\u2013pyrimethamine during pregnancy in Malawi. Malar J. 2017;16(1):84.","journal-title":"Malar J"},{"key":"8471_CR28","volume-title":"Revised guidelines for the treatment of malaria in Malawi","author":"Malawi National Malaria Control Programme","year":"2013","unstructured":"Malawi National Malaria Control Programme. Revised guidelines for the treatment of malaria in Malawi. Lilongwe: Malawi Ministry of Health; 2013."},{"key":"8471_CR29","volume-title":"Provision of effective antenatal care, Integrated management of pregnancy and childbirth (IMPAC). Standards for maternal and neonatal care","author":"WHO","year":"2006","unstructured":"WHO. Provision of effective antenatal care, Integrated management of pregnancy and childbirth (IMPAC). Standards for maternal and neonatal care. Geneva: World Health Organization; 2006. [Accessed on Nov 26, 2015]. Available from http:\/\/www.who.int\/reproductivehealth\/publications\/maternal_perinatal_health\/effective_antenatal_care.pdf. In."},{"issue":"1","key":"8471_CR30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12884-018-1744-y","volume":"18","author":"SC Azizi","year":"2018","unstructured":"Azizi SC, Chongwe G, Chipukuma H, Jacobs C, Zgambo J, Michelo C. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study. BMC Pregnancy Childbirth. 2018;18(1):108.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"8471_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12936-018-2360-z","volume":"17","author":"O Nkoka","year":"2018","unstructured":"Nkoka O, Chuang T-W, Chen Y-H. Association between timing and number of antenatal care visits on uptake of intermittent preventive treatment for malaria during pregnancy among Malawian women. Malar J. 2018;17(1):211.","journal-title":"Malar J"},{"key":"8471_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1756-3305-4-108","volume":"4","author":"TC d'Almeida","year":"2011","unstructured":"d'Almeida TC, Agboton-Zoumenou MA, Garcia A, Massougbodji A, Briand V, Imorou Y, Cottrell G. Field evaluation of the intermittent preventive treatment of malaria during pregnancy (IPTp) in Benin: evolution of the coverage rate since its implementation. Parasit Vectors. 2011;4:108.","journal-title":"Parasit Vectors"},{"issue":"1","key":"8471_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1475-2875-13-22","volume":"13","author":"A Exavery","year":"2014","unstructured":"Exavery A, Mbaruku G, Mbuyita S, Makemba A, Kinyonge IP, Kweka H. Factors affecting uptake of optimal doses of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy in six districts of Tanzania. Malar J. 2014;13(1):13\u201322.","journal-title":"Malar J"},{"issue":"3","key":"8471_CR34","doi-asserted-by":"publisher","first-page":"460","DOI":"10.4269\/ajtmh.2009.80.460","volume":"80","author":"S Gies","year":"2009","unstructured":"Gies S, Coulibaly SO, Ky C, Ouattara FT, Brabin BJ, D'Alessandro U. Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso. Am J Tropical Med Hyg. 2009;80(3):460\u20139.","journal-title":"Am J Tropical Med Hyg"},{"issue":"3","key":"8471_CR35","first-page":"1","volume":"9","author":"J Hill","year":"2014","unstructured":"Hill J, Kayentao K, Tour\u00e9 M, Diarwara S, Bruce J, Smedley J, Doumbo OK, Kuile FO, Webster J. Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Mali: a household survey. PLoS One. 2014;9(3):1\u201313.","journal-title":"PLoS One"},{"key":"8471_CR36","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1475-2875-6-144","volume":"6","author":"L Hommerich","year":"2007","unstructured":"Hommerich L, von Oertzen C, Bedu-Addo G, Holmberg V, Acquah PA, Eggelte TA, Bienzle U, Mockenhaupt FP. Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy. Malar J. 2007;6:144.","journal-title":"Malar J"},{"key":"8471_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13690-016-0116-1","volume":"74","author":"N Leonard","year":"2016","unstructured":"Leonard N, Eric FB, Judith AK, Samuel W. Factors associated to the use of insecticide treated nets and intermittent preventive treatment for malaria control during pregnancy in Cameroon. Arch Public Health. 2016;74:5.","journal-title":"Arch Public Health"},{"issue":"7","key":"8471_CR38","doi-asserted-by":"publisher","first-page":"e22452","DOI":"10.1371\/journal.pone.0022452","volume":"6","author":"C Pell","year":"2011","unstructured":"Pell C, Straus L, Andrew EVW, Me\u00f1aca A, Pool R. Social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: a systematic review of the qualitative research. PLoS One. 2011;6(7):e22452.","journal-title":"PLoS One"},{"key":"8471_CR39","doi-asserted-by":"publisher","first-page":"9278432","DOI":"10.1155\/2019\/9278432","volume":"2019","author":"S Amankwah","year":"2019","unstructured":"Amankwah S, Anto F. Factors associated with uptake of intermittent preventive treatment of malaria in pregnancy: a cross-sectional study in private health facilities in Tema Metropolis, Ghana. J Trop Med. 2019;2019:9278432.","journal-title":"J Trop Med"},{"key":"8471_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1475-2875-7-135","volume":"7","author":"GM Mubyazi","year":"2008","unstructured":"Mubyazi GM, Bygbjerg IC, Magnussen P, Olsen O, Byskov J, Hansen KS, Bloch P. Prospects, achievements, challenges and opportunities for scaling-up malaria chemoprevention in pregnancy in Tanzania: the perspective of national level officers. Malar J. 2008;7:135.","journal-title":"Malar J"},{"key":"8471_CR41","volume-title":"Factsheet on the World Malaria Report","author":"World Health Organization","year":"2013","unstructured":"World Health Organization Factsheet on the World Malaria Report 2013 [http:\/\/www.who.int\/malaria\/media\/world_malaria_report_2013\/en\/]. In."},{"issue":"1","key":"8471_CR42","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1186\/s12889-015-1905-0","volume":"15","author":"SM Kibusi","year":"2015","unstructured":"Kibusi SM, Kimunai E, Hines CS. Predictors for uptake of intermittent preventive treatment of malaria in pregnancy (IPTp) in Tanzania. BMC Public Health. 2015;15(1):540.","journal-title":"BMC Public Health"},{"issue":"1","key":"8471_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-015-0840-y","volume":"14","author":"D Mwandama","year":"2015","unstructured":"Mwandama D, Gutman J, Wolkon A, Luka M, Jafali J, Ali D, Mathanga DP, Skarbinski J. The use of intermittent preventive treatment in pregnancy and insecticide-treated bed nets for malaria prevention by women of child-bearing age in eight districts in Malawi. Malar J. 2015;14(1):1\u201310.","journal-title":"Malar J"},{"issue":"10","key":"8471_CR44","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.trstmh.2007.04.005","volume":"101","author":"A Launiala","year":"2007","unstructured":"Launiala A, Honkasalo M-L. Ethnographic study of factors influencing compliance to intermittent preventive treatment of malaria during pregnancy among Yao women in rural Malawi. Trans R Soc Trop Med Hyg. 2007;101(10):980\u20139.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"8471_CR45","first-page":"9761289","volume":"2017","author":"MB Ayubu","year":"2017","unstructured":"Ayubu MB, Kidima WB. Monitoring compliance and acceptability of intermittent preventive treatment of malaria using sulfadoxine pyrimethamine after ten years of implementation in Tanzania. Malaria Res Treat. 2017;2017:9761289.","journal-title":"Malaria Res Treat"},{"key":"8471_CR46","volume-title":"ICF: Malawi Demographic and Health Survey 2015\u201316","author":"National Statistical Office\/Malawi","year":"2017","unstructured":"National Statistical Office\/Malawi. ICF: Malawi Demographic and Health Survey 2015\u201316. Zomba: National Statistical Office and ICF; 2017."},{"key":"8471_CR47","volume-title":"Applied survey data analysis: chapman and hall\/CRC","author":"SG Heeringa","year":"2017","unstructured":"Heeringa SG, West BT, Berglund PA. Applied survey data analysis: chapman and hall\/CRC; 2017."},{"key":"8471_CR48","doi-asserted-by":"crossref","unstructured":"Hosmer DW Jr, Lemeshow S, Sturdivant RX. Applied logistic regression, vol. 398: Wiley; 2013. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/126340\/9789241507219_eng.pdf.","DOI":"10.1002\/9781118548387"},{"issue":"1","key":"8471_CR49","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12936-019-2883-y","volume":"18","author":"D Okethwangu","year":"2019","unstructured":"Okethwangu D, Opigo J, Atugonza S, Kizza CT, Nabatanzi M, Biribawa C, Kyabayinze D, Ario AR. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda demographic and health survey, 2016. Malar J. 2019;18(1):250.","journal-title":"Malar J"},{"key":"8471_CR50","doi-asserted-by":"publisher","first-page":"5019215","DOI":"10.1155\/2018\/5019215","volume":"2018","author":"O Addai-Mensah","year":"2018","unstructured":"Addai-Mensah O, Annani-Akollor ME, Fondjo LA, Sarbeng K, Anto EO, Owiredu E-W, Arthur SN. Regular antenatal attendance and education influence the uptake of intermittent preventive treatment of malaria in pregnancy: a cross-sectional study at the university hospital, Kumasi, Ghana. J Trop Med. 2018;2018:5019215.","journal-title":"J Trop Med"},{"issue":"1","key":"8471_CR51","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12936-017-1969-7","volume":"16","author":"I Owusu-Boateng","year":"2017","unstructured":"Owusu-Boateng I, Anto F. Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine\u2013pyrimethamine five dose policy in Ghana. Malar J. 2017;16(1):323.","journal-title":"Malar J"},{"issue":"1","key":"8471_CR52","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12936-018-2255-z","volume":"17","author":"P Arnaldo","year":"2018","unstructured":"Arnaldo P, Rovira-Vallbona E, Langa JS, Salvador C, Guetens P, Chiheb D, Xavier B, Kestens L, Enosse SM, Rosanas-Urgell A. Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Ch\u00f3kw\u00e8 district, southern Mozambique. Malar J. 2018;17(1):109.","journal-title":"Malar J"},{"issue":"1","key":"8471_CR53","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12936-018-2512-1","volume":"17","author":"M Henry","year":"2018","unstructured":"Henry M, Florey L, Youll S. Gutman JRJMj: an analysis of country adoption and implementation of the 2012 WHO recommendations for intermittent preventive treatment for pregnant women in sub-Saharan Africa. Malar J. 2018;17(1):364.","journal-title":"Malar J"},{"key":"8471_CR54","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12936-015-0730-3","volume":"14","author":"K Agarwal","year":"2015","unstructured":"Agarwal K, Alonso P, Chico RM, Coleman J, Dellicour S, Hill J, Majeres-Lugand M, Mangiaterra V, Menendez C, Mitchell K, et al. Global call to action to scale-up coverage of intermittent preventive treatment of malaria in pregnancy: seminar report. Malar J. 2015;14:206.","journal-title":"Malar J"},{"issue":"6","key":"8471_CR55","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/1471-0528.14599","volume":"124","author":"\u04e6 Tun\u00e7alp","year":"2017","unstructured":"Tun\u00e7alp \u04e6, Pena-Rosas JP, Lawrie T, Bucagu M, Oladapo OT, Portela A, G\u00fclmezoglu AM. WHO recommendations on antenatal care for a positive pregnancy experience-going beyond survival. J BJOG. 2017;124(6):860\u20132.","journal-title":"J BJOG"},{"issue":"1","key":"8471_CR56","doi-asserted-by":"publisher","first-page":"e53747","DOI":"10.1371\/journal.pone.0053747","volume":"8","author":"C Pell","year":"2013","unstructured":"Pell C, Me\u00f1aca A, Were F, Afrah NA, Chatio S, Manda-Taylor L, Hamel MJ, Hodgson A, Tagbor H, Kalilani L. Factors affecting antenatal care attendance: results from qualitative studies in Ghana. Kenya and Malawi PloS one. 2013;8(1):e53747.","journal-title":"Kenya and Malawi PloS one"},{"key":"8471_CR57","volume-title":"World Health Organization, WHO Policy Brief for the Implementation of Intermittent Preventive Treatment of Malaria in Pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP)","author":"WHO","year":"2013","unstructured":"WHO: World Health Organization, WHO Policy Brief for the Implementation of Intermittent Preventive Treatment of Malaria in Pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP), 2013 [http:\/\/www.who.int\/malaria\/publications\/atoz\/Policy_brief_IPTp-SP_implementation_11april2013.pdf.pdf]. In.: World Health Organization; 2013."},{"key":"8471_CR58","volume-title":"Treatment uptake and availability of antimalarial drugs for intermittent preventative treatment in pregnant women in Malawi","author":"L Bausell","year":"2015","unstructured":"Bausell L, Wolf K. Treatment uptake and availability of antimalarial drugs for intermittent preventative treatment in pregnant women in Malawi. Arlington: USAID|DELIVER PROJECT; 2015. Task Order 7."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-08471-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-020-08471-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-08471-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T20:47:29Z","timestamp":1615841249000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-08471-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,16]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["8471"],"URL":"https:\/\/doi.org\/10.1186\/s12889-020-08471-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.20575\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.20575\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.20575\/v3","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,16]]},"assertion":[{"value":"17 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Malawi Demographic and Health Survey protocol was reviewed and approved by Malawi\u2019s National Health Sciences Research Committee and Inner City Fund Institutional Review Board. Interviewers informed prospective participants about the purpose of the study, procedures required of them if recruited, and that they had the right to volunteer whether or not to participate in the study. Informed consent was obtained from each participant before administering the questionnaire. Written informed consent was obtained from a parent or guardian for participants under 16\u2009years old. The respondents were assured of privacy and confidentiality. To access the survey datasets, the author obtained permission from the Demographic and Health Surveys (DHS) Program. The datasets received were treated as confidential and no effort was made to identify any household or individual respondent interviewed in the survey.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares that he has no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"335"}}